4^th mRNA Analytical Development & Quality Control Summit | February 25-27, 2025

Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running. Yet, despite optimized analytics, critical quality control methodology and robust assay development leading to efficient approvals and commercialization, knowledge gaps persist in phase-appropriate assays, analyzing LNP payloads and novel cell-targeted delivery systems, and controlling dsRNA. Not to mention the challenges posed by regulations!

With exclusive FDA insight, the 4^th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, Quality, and Assay Development teams at one central forum for the first time to finally address shared challenges and cross-department priorities to ensure successful regulatory submissions.

• Dates: February 25-27, 2025
• Location: Revere Hotel Boston Common, Boston, Massachusetts
• Event Program: https://ter.li/h10rnn

Bringing together 100+ Scientists, Directors and Heads of Analytical Development, Quality Control, Assay Development, CMC and Regulatory Affairs, join your peers to take part in critical conversations and ensure the identity, safety and efficacy of your RNA medicines.

Download the agenda here: https://ter.li/h10rnn

View your registration options, early bird savings, and group discounts: https://ter.li/ku4oky